Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial
SBRT has become a standard treatment for patients with medically inoperable early-stage lung cancer. The effectiveness in patients medically suitable for surgery is unclear. The S BRT appears to be associated with a high rate of primary tumor control, low treatment-related morbidity, and infrequent occurrence of cancer recurrence.
